Cell-Free DNA (cfDNA) Testing Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Cell-Free DNA (cfDNA) Testing Market covers analysis by Type ( donor derived cell free DNA (ddcfDNA), circulating cell-free tumor DNA (ctDNA), cell-free fetal DNA (NIPT) ); Application ( oncology, gynecology, transplantation ), and Geography (North America, Europe, Asia Pacific, and South and Central America)

Publication Month : Apr 2024

  • Report Code : TIPRE00011771
  • Category : Biotechnology
  • Status : Upcoming
  • No. of Pages : 150
Inquire Before Buy

PRICING

$5190

$4671

MARKET INTRODUCTION

Cell-Free DNA are fragments of DNA that circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which a small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients, and detect various chromosomal abnormalities in the fetus to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation, and infectious diseases.

MARKET DYNAMICS

The cell-free DNA (cfDNA) testing market is driving due to the Increased incidences of diseases like chromosomal abnormalities due to increase in maternal age, changing lifestyle, unhealthy diet habits and rising prevalence of cancer. However, lack of standardization, unfavorable reimbursement policies and legal and regulatory guidelines some of the reasons hampering the growth of the market. Moreover, increasing healthcare expenditure and rising healthcare awareness are driving the cell-free DNA market.

MARKET SCOPE

The "Cell-Free DNA (cfDNA) Testing Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of cell-free DNA (cfDNA) testing market with detailed market segmentation by type and application. The cell-free DNA (cfDNA) testing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in cell-free DNA (cfDNA) testing market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The cell-free DNA (cfDNA) testing market is segmented on the basis of type and application. Based on type, the market is segmented as donor derived cell free DNA (ddcfDNA), circulating cell-free tumor DNA (ctDNA) and cell-free fetal DNA (NIPT). On the basis of application, the market is categorized as oncology, gynecology and transplantation.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the cell-free DNA (cfDNA) testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell-free DNA (cfDNA) testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting cell-free DNA (cfDNA) testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cell-free DNA (cfDNA) testing market in these regions.

World Geography

Have a question?

Analyst

Akshay

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst   Speak to Analyst
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
MARKET PLAYERS


The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the cell-free DNA (cfDNA) testing market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cell-free DNA (cfDNA) testing market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting cell-free DNA (cfDNA) testing market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cell-free DNA (cfDNA) testing market in these regions.

MARKET PLAYERS

The report covers key developments in the cell-free DNA (cfDNA) testing market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from cell-free DNA (cfDNA) testing market are anticipated to have lucrative growth opportunities in the future with the rising demand for cell-free DNA (cfDNA) testing in the global market. Below mentioned is the list of few companies engaged in the cell-free DNA (cfDNA) testing market.

The report also includes the profiles of key players in cell-free DNA (cfDNA) testing market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Agilent Technology
  •   Allenex AB
  •   Biocept, Inc.
  •   Biodesix, Inc.
  •   CareDx, Inc.
  •   Guardant Health, Inc.
  •   Illumania, Inc.
  •   Inivated Limited, Natera, Inc.
  •   Quest Diagnostics
  •   Roche Holdings AG
  •   Sequenom, Inc.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cell-Free DNA (cfDNA) Testing Market - By Type
1.3.2 Cell-Free DNA (cfDNA) Testing Market - By Application
1.3.3 Cell-Free DNA (cfDNA) Testing Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. CELL-FREE DNA (CFDNA) TESTING MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CELL-FREE DNA (CFDNA) TESTING MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. CELL-FREE DNA (CFDNA) TESTING MARKET - GLOBAL MARKET ANALYSIS
6.1. CELL-FREE DNA (CFDNA) TESTING - GLOBAL MARKET OVERVIEW
6.2. CELL-FREE DNA (CFDNA) TESTING - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. CELL-FREE DNA (CFDNA) TESTING MARKET - REVENUE AND FORECASTS TO 2028 - TYPE
7.1. OVERVIEW
7.2. TYPE MARKET FORECASTS AND ANALYSIS
7.3. DONOR DERIVED CELL FREE DNA (DDCFDNA)
7.3.1. Overview
7.3.2. donor derived cell free DNA (ddcfDNA) Market Forecast and Analysis
7.4. CIRCULATING CELL-FREE TUMOR DNA (CTDNA)
7.4.1. Overview
7.4.2. circulating cell-free tumor DNA (ctDNA) Market Forecast and Analysis
7.5. CELL-FREE FETAL DNA (NIPT)
7.5.1. Overview
7.5.2. cell-free fetal DNA (NIPT) Market Forecast and Analysis
8. CELL-FREE DNA (CFDNA) TESTING MARKET - REVENUE AND FORECASTS TO 2028 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. ONCOLOGY
8.3.1. Overview
8.3.2. oncology Market Forecast and Analysis
8.4. GYNECOLOGY
8.4.1. Overview
8.4.2. gynecology Market Forecast and Analysis
8.5. TRANSPLANTATION
8.5.1. Overview
8.5.2. transplantation Market Forecast and Analysis
9. CELL-FREE DNA (CFDNA) TESTING MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cell-Free DNA (cfDNA) Testing Market Overview
9.1.2 North America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.1.3 North America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.1.4 North America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.1.5 North America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cell-Free DNA (cfDNA) Testing Market
9.1.5.1.1 United States Cell-Free DNA (cfDNA) Testing Market by Type
9.1.5.1.2 United States Cell-Free DNA (cfDNA) Testing Market by Application
9.1.5.2 Canada Cell-Free DNA (cfDNA) Testing Market
9.1.5.2.1 Canada Cell-Free DNA (cfDNA) Testing Market by Type
9.1.5.2.2 Canada Cell-Free DNA (cfDNA) Testing Market by Application
9.1.5.3 Mexico Cell-Free DNA (cfDNA) Testing Market
9.1.5.3.1 Mexico Cell-Free DNA (cfDNA) Testing Market by Type
9.1.5.3.2 Mexico Cell-Free DNA (cfDNA) Testing Market by Application
9.2. EUROPE
9.2.1 Europe Cell-Free DNA (cfDNA) Testing Market Overview
9.2.2 Europe Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.2.3 Europe Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.2.4 Europe Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.2.5 Europe Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cell-Free DNA (cfDNA) Testing Market
9.2.5.1.1 Germany Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.1.2 Germany Cell-Free DNA (cfDNA) Testing Market by Application
9.2.5.2 France Cell-Free DNA (cfDNA) Testing Market
9.2.5.2.1 France Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.2.2 France Cell-Free DNA (cfDNA) Testing Market by Application
9.2.5.3 Italy Cell-Free DNA (cfDNA) Testing Market
9.2.5.3.1 Italy Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.3.2 Italy Cell-Free DNA (cfDNA) Testing Market by Application
9.2.5.4 Spain Cell-Free DNA (cfDNA) Testing Market
9.2.5.4.1 Spain Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.4.2 Spain Cell-Free DNA (cfDNA) Testing Market by Application
9.2.5.5 United Kingdom Cell-Free DNA (cfDNA) Testing Market
9.2.5.5.1 United Kingdom Cell-Free DNA (cfDNA) Testing Market by Type
9.2.5.5.2 United Kingdom Cell-Free DNA (cfDNA) Testing Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Overview
9.3.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.3.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.3.4 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cell-Free DNA (cfDNA) Testing Market
9.3.5.1.1 Australia Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.1.2 Australia Cell-Free DNA (cfDNA) Testing Market by Application
9.3.5.2 China Cell-Free DNA (cfDNA) Testing Market
9.3.5.2.1 China Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.2.2 China Cell-Free DNA (cfDNA) Testing Market by Application
9.3.5.3 India Cell-Free DNA (cfDNA) Testing Market
9.3.5.3.1 India Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.3.2 India Cell-Free DNA (cfDNA) Testing Market by Application
9.3.5.4 Japan Cell-Free DNA (cfDNA) Testing Market
9.3.5.4.1 Japan Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.4.2 Japan Cell-Free DNA (cfDNA) Testing Market by Application
9.3.5.5 South Korea Cell-Free DNA (cfDNA) Testing Market
9.3.5.5.1 South Korea Cell-Free DNA (cfDNA) Testing Market by Type
9.3.5.5.2 South Korea Cell-Free DNA (cfDNA) Testing Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Overview
9.4.2 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.4.3 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.4.4 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cell-Free DNA (cfDNA) Testing Market
9.4.5.1.1 South Africa Cell-Free DNA (cfDNA) Testing Market by Type
9.4.5.1.2 South Africa Cell-Free DNA (cfDNA) Testing Market by Application
9.4.5.2 Saudi Arabia Cell-Free DNA (cfDNA) Testing Market
9.4.5.2.1 Saudi Arabia Cell-Free DNA (cfDNA) Testing Market by Type
9.4.5.2.2 Saudi Arabia Cell-Free DNA (cfDNA) Testing Market by Application
9.4.5.3 U.A.E Cell-Free DNA (cfDNA) Testing Market
9.4.5.3.1 U.A.E Cell-Free DNA (cfDNA) Testing Market by Type
9.4.5.3.2 U.A.E Cell-Free DNA (cfDNA) Testing Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cell-Free DNA (cfDNA) Testing Market Overview
9.5.2 South and Central America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis
9.5.3 South and Central America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Type
9.5.4 South and Central America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Application
9.5.5 South and Central America Cell-Free DNA (cfDNA) Testing Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cell-Free DNA (cfDNA) Testing Market
9.5.5.1.1 Brazil Cell-Free DNA (cfDNA) Testing Market by Type
9.5.5.1.2 Brazil Cell-Free DNA (cfDNA) Testing Market by Application
9.5.5.2 Argentina Cell-Free DNA (cfDNA) Testing Market
9.5.5.2.1 Argentina Cell-Free DNA (cfDNA) Testing Market by Type
9.5.5.2.2 Argentina Cell-Free DNA (cfDNA) Testing Market by Application
10. IMPACT OF COVID-19 PANDEMIC ON GLOBAL CELL-FREE DNA (CFDNA) TESTING MARKET
10.1 North America
10.2 Europe
10.3 Asia-Pacific
10.4 Rest of the World
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. CELL-FREE DNA (CFDNA) TESTING MARKET, KEY COMPANY PROFILES
12.1. AGILENT TECHNOLOGY
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. ALLENEX AB
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. BIOCEPT, INC.
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. BIODESIX, INC.
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. CAREDX, INC.
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. GUARDANT HEALTH, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ILLUMANIA, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. INIVATED LIMITED, NATERA, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. QUEST DIAGNOSTICS
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. ROCHE HOLDINGS AG
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
12.11. SEQUENOM, INC.
12.11.1. Key Facts
12.11.2. Business Description
12.11.3. Products and Services
12.11.4. Financial Overview
12.11.5. SWOT Analysis
12.11.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Agilent Technology
2. Allenex AB
3. Biocept, Inc.
4. Biodesix, Inc.
5. CareDx, Inc.
6. Guardant Health, Inc.
7. Illumania, Inc.
8. Inivated Limited, Natera, Inc.
9. Quest Diagnostics
10. Roche Holdings AG
11. Sequenom, Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Cell-Free DNA (cfDNA) Testing Market